Fmoc-D-Asp-ODmb

Fmoc-D-Asp-ODmb is an Fmoc-protected D-aspartic acid derivative in which the side-chain carboxyl group is masked as an ODmb ester (ODmb = 2,2-dimethoxybenzyl), while the α-amino group is protected by the fluorenylmethoxycarbonyl (Fmoc) group. The molecule contains both an Fmoc carbamate and an esterified side-chain carboxyl functionality, with the amino-acid backbone retaining the D stereochemical form as indicated by the product name. In peptide chemistry, this protected amino acid is used as a building block for stepwise coupling under conditions compatible with orthogonal deprotection of the Fmoc group and subsequent removal of the ODmb ester to regenerate the free aspartate side-chain carboxyl for controlled peptide or peptide-conjugate assembly.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP26643

CAS No:200335-63-3

Synonyms/Alias:Fmoc-D-Asp-ODmb;ZINC15722159;AM019610;(3R)-4-[(2,4-DIMETHOXYPHENYL)METHOXY]-3-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}-4-OXOBUTANOICACID;200335-63-3

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C28H27NO8
M.W/Mr.
505.53

Fmoc-D-Asp-ODmb is a chiral, N-(9H-fluoren-9-ylmethoxycarbonyl) protected aspartic acid derivative in the D-configuration, bearing a side-chain carboxyl group masked as an O-Dmb (2,2-dimethylbenzhydryl) ester. The molecule combines an Fmoc-protected alpha-amino functionality for orthogonal peptide coupling with a stereodefined alpha-carbon that can control sequence-level stereochemistry in peptide and peptidomimetic assemblies. The Dmb ester is acid-labile under conditions commonly used for side-chain deprotection, enabling late-stage unveiling of the side-chain carboxyl for further derivatization or native peptide formation. The resulting amphoteric profile after deprotection, together with the robust Fmoc carbamate, supports predictable orthogonal protection strategies and downstream conversion into aspartate-containing intermediates for synthetic organic chemistry and biochemical research.

1. Peptide Synthesis

Fmoc-D-Asp-ODmb is used in peptide building workflows where Fmoc-based N-protection supports standard stepwise peptide coupling and base-mediated Fmoc removal. The D-Asp backbone stereochemistry and the side-chain carboxyl hidden as an O-Dmb ester provide controlled access to an aspartate residue during synthesis, allowing selective deprotection and minimizing side reactions from the acidic side chain. The orthogonal protection pattern enables incorporation of D-Asp into peptides, peptide fragments, or cyclic scaffolds while deferring side-chain activation until the final stages. The deprotected side-chain carboxyl can then participate in amide bond formation, esterification, or salt formation, supporting downstream generation of D-Asp-containing analogs for structure-activity relationship studies and peptide chemistry development.

2. Side-Chain Functionalization

Fmoc-D-Asp-ODmb is applied in amino acid derivatization programs that require orthogonal unveiling of an aspartate side-chain carboxyl group from a protected state. The O-Dmb ester masking strategy allows the side-chain to remain inert during N-terminal peptide assembly, while subsequent Dmb removal can generate a free carboxylic acid suitable for coupling to amines, alcohols, or activated electrophiles. The D-configuration provides stereochemical control for producing D-aspartate derivatives that may be used to tune backbone recognition, charge distribution, and conformational preferences in synthetic scaffolds. The resulting functionalized aspartate products can serve as intermediates for peptidomimetic construction, linker installation, and modular synthesis of carboxyl-bearing fragments used in biochemical probe development.

3. Chemical Biology Probes

Fmoc-D-Asp-ODmb is suitable for chemical biology applications where D-aspartate residues and carboxyl-functional linkers are incorporated into labeled peptides or affinity reagents. The Fmoc-protected amine supports controlled assembly of peptide probes, while the protected side-chain carboxyl enables site-specific introduction of handles after deprotection, including conjugation to amines or attachment of reporter moieties through carboxyl-derivatization chemistry. The stereodefined D-Asp center can be leveraged to modulate protease stability and recognition patterns in peptide-based probes used for target engagement studies and molecular interaction mapping. The protected-to-deprotected transition inherent to the Fmoc/O-Dmb strategy supports reproducible synthesis of carboxyl-bearing probe intermediates for downstream conjugation and analytical characterization.

4. Pharmaceutical Intermediate Preparation

Fmoc-D-Asp-ODmb is employed as a process-relevant protected amino acid intermediate for manufacturing routes that require incorporation of D-aspartate motifs into peptidic or peptidomimetic drug candidates. The Fmoc carbamate and O-Dmb ester provide orthogonal protection that can be aligned with scalable peptide coupling conditions and controlled deprotection steps, supporting reliable generation of D-Asp-containing intermediates for further functional group transformations. The side-chain carboxyl, once unmasked, can be converted into activated acid derivatives for subsequent coupling steps in synthesis of larger molecules, including amide-forming intermediates and salt-forming species for formulation work. The compound's defined stereochemistry and protection logic make it compatible with industrial fine chemical synthesis where protected amino acid building blocks are assembled into higher molecular weight targets.

5. Analytical Research Standards

Fmoc-D-Asp-ODmb can be utilized in analytical research for preparing defined D-aspartate-containing standards, calibration materials, and reference fragments used in method development. The Fmoc-protected N-terminus and Dmb-protected side-chain carboxyl enable synthesis of clean, well-defined peptide or fragment standards that can be generated with controlled deprotection states for LC-MS, HPLC, or electrophoretic analysis. The stereochemical integrity of the D-Asp residue supports unambiguous discrimination from L-aspartate analogs in stereospecific workflows. The ability to generate both protected and deprotected forms from the same chiral starting material supports robust analytical method validation across peptide coupling, deprotection, and derivatization stages in biochemical research pipelines.

Size
1 g;5 g;
InChI
1S/C28H27NO8/c1-34-18-12-11-17(25(13-18)35-2)15-36-27(32)24(14-26(30)31)29-28(33)37-16-23-21-9-5-3-7-19(21)20-8-4-6-10-22(20)23/h3-13,23-24H,14-16H2,1-2H3,(H,29,33)(H,30,31)/t24-/m1/s1
InChI Key
ODIFVCRSTRBDDR-XMMPIXPASA-N
Canonical SMILES
COC1=CC(=C(C=C1)COC(=O)C(CC(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)OC

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Modification ServicesPeptide CDMOPeptide Analysis ServicesPeptide Nucleic Acids SynthesiscGMP Peptide ServiceEpitope Mapping ServicesPeptide Synthesis ServicesCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers